1845PSafety, clinical activity and pharmacological...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1845PSafety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials

Mau-Sorensen, M, van Bussel, M, Kuipers, M, Nielsen, D L, Verheul, H M, Aftimos, P, de Jonge, M J A, van Triest, B, Falkenius, J, Debus, J, Troost, E, Samuels, M, Sarholz, B, Budach, V, Goel, S, Locat
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy303.015
Date:
October, 2018
File:
PDF, 76 KB
english, 2018
Conversion to is in progress
Conversion to is failed